We are live on ! Find out more
TCM

TimesSquare Capital Management Portfolio holdings

AUM $6.8B
1-Year Est. Return 45.85%
This Fund
S&P 500
This Quarter Est. Return
+37.58%
1 Year Est. Return
+45.85%
3 Year Est. Return
+131.54%
5 Year Est. Return
+149.79%
10 Year Est. Return
+765.84%
AUM
$10.5B
AUM Growth
+$2.1B
Cap. Flow
-$429M
Cap. Flow %
-4.09%
Top 10 Hldgs %
13.09%
Holding
245
New
23
Increased
75
Reduced
125
Closed
18

Top Buys

Rank Stock Value
1
NEWR
New Relic, Inc.
NEWR
+$64.1M
2
BILL icon
BILL Holdings
BILL
+$53.1M
3
IMMU
Immunomedics Inc
IMMU
+$52.9M
4
ATRC icon
AtriCure
ATRC
+$51.2M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$49.1M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$120M
2
CBRE icon
CBRE Group
CBRE
+$89.6M
3
CHGG icon
Chegg
CHGG
+$66M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$56.2M
5
DOX icon
Amdocs
DOX
+$51.5M

Sector Composition

Rank Sector Weight
1 Technology 31.1%
2 Healthcare 19.47%
3 Industrials 14.73%
4 Consumer Discretionary 9.8%
5 Financials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BURL icon
51
Burlington
BURL
$14.6B
$65.3M 0.62%
331,400
+50,975
+18% +$9.6M
SNPS icon
52
Synopsys
SNPS
$73.1B
$65M 0.62%
333,100
+700
+0.2% +$116K
MRVL icon
53
Marvell Technology
MRVL
$197B
$64.7M 0.62%
1,846,800
-1,573,200
-46% -$46.1M
IMMU
54
DELISTED
Immunomedics Inc
IMMU
$64.2M 0.61%
+1,811,000
New +$52.9M
NICE icon
55
Nice
NICE
$6.25B
$64.1M 0.61%
338,550
+215,700
+176% +$37.8M
LHX icon
56
L3Harris
LHX
$46.4B
$63.8M 0.61%
376,100
+50,400
+15% +$9.47M
VRSK icon
57
Verisk Analytics
VRSK
$24.3B
$63.7M 0.61%
374,455
-31,400
-8% -$4.96M
TYL icon
58
Tyler Technologies
TYL
$14.7B
$63.2M 0.6%
182,085
-98,890
-35% -$33.2M
PPLI
59
People Inc
PPLI
$2.9B
$62.6M 0.6%
1,083,271
-204,652
-16% -$9.09M
MPWR icon
60
Monolithic Power Systems
MPWR
$56.2B
$62.5M 0.6%
263,650
-63,800
-19% -$12.9M
MLM icon
61
Martin Marietta Materials
MLM
$35.6B
$61.4M 0.59%
297,000
-47,700
-14% -$9.17M
STRA icon
62
Strategic Education
STRA
$1.84B
$61.3M 0.58%
398,865
-69,044
-15% -$10.8M
TEAM icon
63
Atlassian
TEAM
$48.8B
$60.5M 0.58%
335,800
-48,700
-13% -$8.09M
BPMC
64
DELISTED
Blueprint Medicines
BPMC
$60M 0.57%
768,850
+2,305
+0.3% +$156K
KEYS icon
65
Keysight
KEYS
$53.6B
$59.9M 0.57%
593,900
+126,200
+27% +$12.4M
MCHP icon
66
Microchip Technology
MCHP
$38.8B
$59.8M 0.57%
1,136,600
+365,000
+47% +$16.4M
TSCO icon
67
Tractor Supply
TSCO
$17.6B
$59M 0.56%
2,237,500
-838,000
-27% -$18.3M
HLNE icon
68
Hamilton Lane
HLNE
$5.31B
$58.7M 0.56%
870,750
+73,020
+9% +$4.6M
ADUS icon
69
Addus HomeCare
ADUS
$2.19B
$58.5M 0.56%
631,900
-78,450
-11% -$6.79M
ZWS icon
70
Zurn Elkay Water Solutions
ZWS
$7.64B
$57.3M 0.55%
4,083,907
-771,836
-16% -$10.1M
CYBR
71
DELISTED
CyberArk
CYBR
$57.2M 0.55%
576,625
+133,400
+30% +$13M
BLUE
72
DELISTED
bluebird bio
BLUE
$57.2M 0.55%
72,382
+11,682
+19% +$8.81M
MKSI icon
73
MKS Inc
MKSI
$16.2B
$56.9M 0.54%
502,510
-58,290
-10% -$5.8M
PRAH
74
DELISTED
PRA Health Sciences, Inc.
PRAH
$56M 0.53%
575,660
+335,660
+140% +$31.2M
CPAY icon
75
Corpay
CPAY
$27.1B
$55.7M 0.53%
221,600
+91,400
+70% +$21.7M
1 2
3
4 5

Similar funds

CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.76B AUM 18.39% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

TimesSquare Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, TimesSquare Capital Management held 245 positions worth $10.5B, up 25% from $8.39B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

TimesSquare Capital Management withdrew a net $429M in Q2 2020, closing 18 positions and reducing 125 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $56.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, TimesSquare Capital Management opened a new position in Immunomedics Inc worth $64.2M.

  • TimesSquare Capital Management's largest Q2 2020 buy was Immunomedics Inc: 1,811,000 shares worth $64.2M.
  • TimesSquare Capital Management added most to New Relic, Inc. in Q2 2020, an estimated $64.1M increase.
  • TimesSquare Capital Management's biggest Q2 2020 reduction was Vertex Pharmaceuticals, cutting an estimated $120M.
  • TimesSquare Capital Management fully exited Alexion Pharmaceuticals in Q2 2020, selling an estimated $56.2M.
  • TimesSquare Capital Management's ten largest holdings make up 13% of its $10.5B portfolio in Q2 2020.
  • TimesSquare Capital Management opened 23 new positions and closed 18 in Q2 2020.
  • TimesSquare Capital Management's portfolio value rose 25% quarter-over-quarter to $10.5B.

Based on TimesSquare Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.